Oscar Health, Inc. Class A Common Stock (OSCR)

Oscar Health Inc (NYSE:OSCR) shares are climbing on Thursday. The company posted fourth‑quarter results that missed expectations on both revenue and earnings, but had a stronger‑than‑expected 2026 outlook.

2025 was a horrible year for the industry, but 2026 is a completely different story.

Health insurance company Oscar Health (NYSE:OSCR) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 17.3% year on year to $2.81 billion. On the other hand, the company’s full-year revenue guidance of $18.85 billion at the midpoint came in 47.8% above analysts’ estimates. Its non-GAAP loss of $1.24 per share was 34.6% below analysts’ consensus estimates.

Investors were encouraged by a positive projection in the company's fourth quarter.

Shares of health insurance company Oscar Health (NYSE:OSCR) jumped 4.8% in the morning session after the company provided an optimistic financial outlook for 2026 that overshadowed its fourth-quarter 2025 earnings miss. The health insurer reported a fourth-quarter loss of $1.24 per share, which was wider than analyst estimates, while revenue of $2.81 billion also fell short of expectations. However, investors looked past the mixed results and focused on the company's ambitious forecast. For the full year 2026, Oscar Health projected revenue of $18.85 billion at the midpoint, significantly higher than the analyst consensus of approximately $12.76 billion, signaling healthy demand for its products and services.

Oscar Health OSCR Q4 2025 Earnings Call Transcript

Health insurance company Oscar Health (NYSE:OSCR) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 17.3% year on year to $2.81 billion. On the other hand, the company’s full-year revenue guidance of $18.85 billion at the midpoint came in 47.8% above analysts’ estimates. Its GAAP loss of $1.24 per share was 43.7% below analysts’ consensus estimates.

Oscar’s earnings come as ACA enrollment shows early signs of cooling.

Health insurance company Oscar Health (NYSE:OSCR) will be reporting results this Tuesday before market open. Here’s what to expect.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

This company is proving that you can win in insurance with a better customer experience.

Oscar Health Inc (NYSE: OSCR) shares are trading lower Tuesday morning as investors react to a surprise Medicare Advantage update from the Trump administration.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

Shares of health insurance company Oscar Health (NYSE:OSCR) fell 2.1% in the morning session after institutional investor Blue Square Asset Management, LLC, disclosed it sold its entire stake in the company. 

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Oscar Health (NYSE:OSCR) and its peers.

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.

Health insurance company, Oscar Health Inc. (NYSE: OSCR) is up 6.69% in after-hours trading on Thursday, at $18.04 per share.

The House vote also reignited criticism from Republicans who oppose extending the subsidies.

With enhanced ACA subsidies now expired, average out-of-pocket premiums for Obamacare users are expected to more than double.

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 17.2% over the past six months, topping the S&P 500 by 7.1 percentage points.